Silence Therapeutics (SLN) Goodwill & Intangibles (2018 - 2026)

Silence Therapeutics (SLN) has 9 years of Goodwill & Intangibles data on file, last reported at $10.6 million in Q1 2026.

• For the quarter ending Q1 2026, Goodwill & Intangibles fell 2.97% year-over-year to $10.6 million; the trailing twelve-month figure through Mar 2026 stood at $10.6 million (down 2.97% YoY), and the FY2025 full-year result was $10.9 million, up 12.42% from the prior year.
• Goodwill & Intangibles eased to $10.6 million in Q1 2026, from $10.9 million in the prior quarter.
• In the past five years, Goodwill & Intangibles ranged from a high of $10.9 million in Q2 2025 to a low of $9.4 million in Q3 2024.
• A 5-year average of $10.3 million and a median of $10.3 million in 2026 frame the typical range for Goodwill & Intangibles.
• Across the five-year window, Goodwill & Intangibles fell 6.15% in 2022 and gained 16.18% in 2025, its largest moves.
• Tracing SLN's Goodwill & Intangibles over 5 years: stood at $9.8 million in 2022, then climbed by 3.21% to $10.1 million in 2023, then dropped by 3.76% to $9.7 million in 2024, then increased by 12.42% to $10.9 million in 2025, then retreated by 2.78% to $10.6 million in 2026.
• Business Quant data shows SLN's Goodwill & Intangibles at $10.6 million in Q1 2026, $10.9 million in Q4 2025, and $10.9 million in Q3 2025.